Glutathione is crucial in neutralizing this surge of free radicals, protecting immune cells and surrounding tissues from damage
Oral protocols throughout the dataset varied substantially: once-daily administration multiple daily administrations intermittent cycling low-dose maintenance protocols high-frequency experimental use Without controlled research data, this cannot be treated as clinical facts, making the independent evaluation of oral versus injectable effectiveness difficult
Strong evidence should include improved recipient-cell bioenergetics, tracking of donor-specific mitochondrial DNA or proteins, ultrastructural or high-resolution live-cell confirmation, loss-of-function experiments, and functional rescue [31,32,33,34,35]
Dalmasso and colleagues (Gastroenterology, 2008, PMID 18061177) reported that KPV is taken up through the di- and tripeptide transporter PepT1, which is normally expressed in the small intestine and induced in the colon during inflammation, and that uptake was associated with reduced NF-B activation in human epithelial and immune cell lines